✦ LIBER ✦

Effects of race and insurance status on serum prostate specific antigen (PSA) levels in localized prostate cancer patients

✍ Scribed by Srinivasan Vijayakumar; Ralph R. Weichselbaum

Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 125 KB
Volume: 30
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(94)90797-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of serum prostate specific me

Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients

✍ Thomas H. Douglas; Ted O. Morgan; David G. McLeod; Judd W. Moul; Gerald P. Murph 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

ated with higher pathologic stage and grade in patients undergoing radical prostatectomy (RP). In earlier studies, serum prostate specific membrane antigen (PSMA)

Clinical features of patients who presen

Clinical features of patients who present with metastatic prostate carcinoma and serum prostate-specific antigen (PSA) levels < 10 ng/mL : The “PSA negative” patients

✍ Alison J. Birtle; Alex Freeman; John R. W. Masters; Heather A. Payne; Stephen J. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 1 views

## Background: Although < 1% of men present with prostate-specific antigen (psa)-negative prostate carcinoma, in that they have serum psa levels much lower than the tumor burden would suggest, such patients represent a management dilemma. to the authors' knowledge, little information exists in the

Pretreatment serum prostate-specific ant

Pretreatment serum prostate-specific antigen (PSA) level and PSA doubling times (PSADT) in black and white men with prostate cancer referred for radiation therapy

✍ W. Robert Lee; Gerald E. Hanks; Alexandra Hanlon; Timothy E. Schultheiss 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB 👁 1 views

Numerous racial differences have been reported for carcinoma of the prostate diagnosed in African-American (AA) men when compared to whites. These differences include: (1) a higher incidence in AA compared to whites, (2) a more advanced stage at diagnosis in A4, and (3) higher mortality rates in AA

Spontaneous circadian fluctuations of pr

Spontaneous circadian fluctuations of prostate specific antigen and prostatic acid phosphatase serum activities in patients with prostatic cancer

✍ Mannini, D. ;Maver, P. ;Aiello, E. ;Corrado, G. ;Vecchi, F. ;Bellanova, B. ;Mare 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 355 KB

Presalvage prostate-specific antigen (PS

Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy

✍ Philippe E. Spiess; Andrew K. Lee; Dan Leibovici; Xuemei Wang; Kim-Anh Do; Louis 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

Elevated levels of prostate-specific ant

Elevated levels of prostate-specific antigen (PSA) in prostate cancer cells expressing mutant p53 is associated with tumor metastasis

✍ Sean Downing; Clare Bumak; Sheri Nixdorf; Kim Ow; Pamela Russell; Paul Jackson 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB

## Abstract The underlying basis for rising levels of prostate‐specific antigen (PSA) in prostate cancer is not fully understood, but attention has turned to the possibility that loss of normal p53 function might be directly involved. We have investigated the relationship between p53 function and P